181 related articles for article (PubMed ID: 34293455)
1. An integrated approach to uncover anti-tumor active materials of Curcumae Rhizoma-Sparganii Rhizoma based on spectrum-effect relationship, molecular docking, and ADME evaluation.
Liu XY; Chang YL; Wang XH; Wang Y; Ren XY; Ma JM; Yu AX; Wei J; Fan QQ; Dong Y; Song RL; Yao JL; Shan DJ; She GM
J Ethnopharmacol; 2021 Nov; 280():114439. PubMed ID: 34293455
[TBL] [Abstract][Full Text] [Related]
2. Anti-tumor activity and linear-diarylheptanoids of herbal couple Curcumae Rhizoma-Sparganii Rhizoma and the single herbs.
Chang YL; Xu GL; Wang XP; Yan X; Xu X; Li X; Chen ZK; Ren X; Chen XQ; Zhang JH; Wang XH; Ren XY; Liu XY; Wang Y; Sun SQ; Li X; She GM
J Ethnopharmacol; 2020 Mar; 250():112465. PubMed ID: 31821851
[TBL] [Abstract][Full Text] [Related]
3. Chemical Composition, Antioxidative and Anticancer Activities of the Essential Oil: Curcumae Rhizoma-Sparganii Rhizoma, a Traditional Herb Pair.
Xu GL; Geng D; Xie M; Teng KY; Tian YX; Liu ZZ; Yan C; Wang Y; Zhang X; Song Y; Yang Y; She GM
Molecules; 2015 Aug; 20(9):15781-96. PubMed ID: 26343630
[TBL] [Abstract][Full Text] [Related]
4. Active ingredients screening and pharmacological mechanism research of curcumae rhizoma-sparganii rhizoma herb pair ameliorates liver fibrosis based on network pharmacology.
Hao M; Yao Z; Zhao M; Chen Z; Wang P; Sang X; Yang Q; Wang K; Han X; Cao G
J Ethnopharmacol; 2023 Apr; 305():116111. PubMed ID: 36592822
[TBL] [Abstract][Full Text] [Related]
5.
Wei J; Wang X; Dong Y; Zhong X; Ren X; Song R; Ma J; Yu A; Fan Q; Yao J; Shan D; Lv F; Zheng Y; Deng Q; Li X; He Y; Fan S; Zhao C; Wang X; Yuan R; She G
Front Pharmacol; 2022; 13():1027687. PubMed ID: 36561345
[No Abstract] [Full Text] [Related]
6. Exploring the mechanism of action of Sparganii Rhizoma-Curcumae Rhizoma for in treating castration-resistant prostate cancer: a network-based pharmacology and experimental validation study.
Wu L; Chen H; Long Y; Qiu J; Dai X; You X; Li T
Sci Rep; 2024 Feb; 14(1):3099. PubMed ID: 38326539
[TBL] [Abstract][Full Text] [Related]
7. An integrated serum and urinary metabonomic research of Rhizoma Curcumae-Rhizoma Sparganii drug pair in hysteromyoma rats based on UPLC-Q-TOF-MS analysis.
Li W; Hong B; Li Q; Li Z; Bi K
J Ethnopharmacol; 2019 Mar; 231():374-385. PubMed ID: 30476536
[TBL] [Abstract][Full Text] [Related]
8. The role of curcumae rhizoma-sparganii rhizoma medicated serum in epithelial-mesenchymal transition in the triple negative breast cancer: Pharmacological role of CR-SR in the TBNC.
Yin Y; Feng L; Wang L; Ding L
Biomed Pharmacother; 2018 Mar; 99():340-345. PubMed ID: 29358127
[TBL] [Abstract][Full Text] [Related]
9. [Prediction of material basis and mechanism of Curcumae Rhizoma in treatment of coronary heart disease].
Fei CH; Tong HJ; Li Y; Xu Z; Qin YW; Bian ZH; Su LL; Ji D; Lu TL; Mao CQ
Zhongguo Zhong Yao Za Zhi; 2022 Jun; 47(12):3270-3284. PubMed ID: 35851121
[TBL] [Abstract][Full Text] [Related]
10. Identification of formononetin as the active compound of CR-SR in hepatocellular carcinoma treatment: An integrated approach combining network pharmacology and weighted gene co-expression networks.
Li C; Xie Y; Hu S; Yu H; Xu Y; Shen H; Yuan Y; Gu L; Pu B
Chem Biol Drug Des; 2024 Jan; 103(1):e14363. PubMed ID: 37793997
[TBL] [Abstract][Full Text] [Related]
11. Identification and quantification of the quality markers and anti-migraine active components in Chuanxiong Rhizoma and Cyperi Rhizoma herbal pair based on chemometric analysis between chemical constituents and pharmacological effects.
Guo L; Gong M; Wu S; Qiu F; Ma L
J Ethnopharmacol; 2020 Jan; 246():112228. PubMed ID: 31513838
[TBL] [Abstract][Full Text] [Related]
12. [Nature-effect relationship research of Curcumae Longae Rhizoma,Curcumae Radix,and Curcumae Rhizoma based on nature combination].
Wu DX; Hou N; Li J; Liu M; Zhang YL; Qiao YJ
Zhongguo Zhong Yao Za Zhi; 2019 Jan; 44(2):229-234. PubMed ID: 30989938
[TBL] [Abstract][Full Text] [Related]
13. Study of the active ingredients and mechanism of Sparganii rhizoma in gastric cancer based on HPLC-Q-TOF-MS/MS and network pharmacology.
Lu X; Zheng Y; Wen F; Huang W; Chen X; Ruan S; Gu S; Hu Y; Teng Y; Shu P
Sci Rep; 2021 Jan; 11(1):1905. PubMed ID: 33479376
[TBL] [Abstract][Full Text] [Related]
14. Screen of anti-migraine active compounds from Duijinsan by spectrum-effect relationship analysis and molecular docking.
Zheng G; Gan L; Jia LY; Zhou DC; Bi S; Meng ZQ; Guan GJ; Huang MM; He X; Zhang CF; Wang CZ; Yuan CS
J Ethnopharmacol; 2021 Oct; 279():114352. PubMed ID: 34161797
[TBL] [Abstract][Full Text] [Related]
15. Anti-cancer effects of Grailsine-Al-glycoside isolated from Rhizoma Sparganii.
Zhang JW; Wei YH
BMC Complement Altern Med; 2014 Mar; 14():82. PubMed ID: 24589031
[TBL] [Abstract][Full Text] [Related]
16. Sparganii Rhizoma: A review of traditional clinical application, processing, phytochemistry, pharmacology, and toxicity.
Jia J; Li X; Ren X; Liu X; Wang Y; Dong Y; Wang X; Sun S; Xu X; Li X; Song R; Ma J; Yu A; Fan Q; Wei J; Yan X; Wang X; She G
J Ethnopharmacol; 2021 Mar; 268():113571. PubMed ID: 33181282
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of multiple representative components in the herb pair Astragali Radix-Curcumae Rhizoma and its single herbs by UPLC-QQQ-MS.
Yin G; Cheng X; Tao W; Dong Y; Bian Y; Zang W; Tang D
J Pharm Biomed Anal; 2018 Jan; 148():224-229. PubMed ID: 29055246
[TBL] [Abstract][Full Text] [Related]
18. [Study on quality evaluation of Sparganii rhizoma by biopotency determination method].
Chen GY; Wu QN; Wang XS; Liang QL; He XX
Zhongguo Zhong Yao Za Zhi; 2012 Oct; 37(19):2913-6. PubMed ID: 23270233
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic based study on "lagged stimulation" of Curcumae Longae Rhizoma - Piper nigrum couplet in their main active components' metabolism using UPLC-MS-MS.
Chen Z; Sun D; Bi X; Zeng X; Luo W; Cai D; Zeng Q; Xu A
Phytomedicine; 2017 Apr; 27():15-22. PubMed ID: 28314475
[TBL] [Abstract][Full Text] [Related]
20. Uncovering the molecular mechanisms of Curcumae Rhizoma against myocardial fibrosis using network pharmacology and experimental validation.
Zhang M; Lu P; Zhao F; Sun X; Ma W; Tang J; Zhang C; Ji H; Wang X
J Ethnopharmacol; 2023 Jan; 300():115751. PubMed ID: 36162550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
